Materiały źródłowe

• #1 Leukemia and Other Blood Cancers: Systemic Mastocytosis | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/leukemias/types/systemic-mastocytosis

  Mastocytosis happens when too many mast cells build up in the body. Mast cells are a type of white blood cell that play an important role in helping the immune system defend the body from disease. They also respond to allergic reactions, help heal wounds, and defend against infections. […] In systemic mastocytosis, however, there are too many mast cells throughout the body, including in the gastrointestinal tract and the bone marrow. When the disease is in the intestinal tract, it can lead to nausea, vomiting, diarrhea, and abdominal pain. […] Our doctors typically treat the illness with antihistamines, drugs that are used for people with allergies. For more severe cases, we may recommend steroid or chemotherapy treatment. A targeted drug called midostaurin (Rydapt) is approved to treat more-aggressive cases of systemic mastocytosis. Finally, our scientists are researching new drugs for people with systemic mastocytosis that carries certain mutations.

• #2 Mastocytosis: Symptoms and Treatment | Rencic Dermatology

  https://www.rencicderm.com/conditions/mastocytosis

  Mastocytosis, a disorder affecting both children and adults, is characterized by an excess of mast cells throughout the body. […] Despite its rarity, mastocytosis can significantly impact your well-being. At Rencic Dermatology, our experts provide tailored treatment plans to alleviate symptoms and improve your quality of life. […] Preventing mastocytosis isn’t currently possible due to its primarily genetic origin, involving mutations affecting mast cells. However, individuals can take proactive steps to manage their symptoms and enhance their quality of life. This involves identifying and avoiding triggers that can worsen mast cell activation and symptoms, such as certain foods, medications, environmental factors, and emotional stressors. […] While mastocytosis cannot be prevented, you can empower yourself to lead a fulfilling life while effectively managing your symptoms and minimizing their impact on your overall well-being with guidance and recommendations from knowledgeable healthcare providers.

• #3 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Mastocytosis is a group of heterogeneous disorders resulting from the clonal proliferation of abnormal mast cells and their accumulation in the skin and/or in various extracutaneous organs. Systemic mastocytosis is the most common form of mastocytosis diagnosed in adults, characterized by mast cell infiltration of one or more extracutaneous organs (with or without skin involvement). […] The management of patients with mastocytosis requires a multidisciplinary team approach (involving dermatologists, hematologists, gastroenterologists, pathologists, and allergists/immunologists) preferably in specialized medical centers with expertise in the treatment of patients with mast cell disorders. […] These NCCN Guidelines provide recommendations for the diagnosis and management of patients with SM. Management of CM is not included in these guidelines. Referral to centers with expertise in CM is strongly recommended.

• #4 Mastocytosis: Types, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/5908-mastocytosis

  Most people can manage mastocytosis symptoms with medication and by avoiding activities and environments that trigger the condition. […] Healthcare providers cant cure mastocytosis, but they can treat its symptoms and the complications the condition causes. […] Treatment varies based on mastocytosis type and your symptoms. In general, providers use medications and other treatments to ease symptoms. […] Providers may use a variety of treatments for mastocytosis symptoms. Most treatments have side effects, some more serious than others. If you have mastocytosis, your provider will explain what you can expect, including treatment side effects. […] If you have systemic mastocytosis, you should always carry a self-injecting syringe of epinephrine, a hormone made by adrenal glands. Epinephrine treats severe allergic reactions that could become life-threatening anaphylactic shock.

• #5 Systemic Mastocytosis: Causes, Symptoms, Diagnosis, and Treatment

  https://www.webmd.com/allergies/systemic-mastocytosis

  Systemic mastocytosis is a disease where too many abnormal mast cells (a type of white blood cell) build up in your skin and other organs. […] There’s no cure, but treatments can help you manage the condition. […] Consider reaching out to family and friends for support as you manage this disease. They can help you deal with the emotions and stress that come with the challenges of a long-term condition like systemic mastocytosis. […] One of the best ways to manage systemic mastocytosis is to avoid triggers. You’ll want to talk to your doctor and keep track of all the things that cause your symptoms, such as stress or spicy food. […] Because the disease can cause a life-threatening allergic reaction, you’ll also want to carry an epinephrine auto-injector at all times. […] Whatever type you have, after your diagnosis, you’ll go to regular follow-up appointments with your doctor. They’ll track your disease and check that your treatments are working. […] If you find that the challenges of managing your disease are making you depressed or anxious, talk to your doctor. They can put you in touch with mental health professionals who are experts in treating these problems.

• #6 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #7 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Mastocytosis is a group of heterogeneous disorders resulting from the clonal proliferation of abnormal mast cells and their accumulation in the skin and/or in various extracutaneous organs. Systemic mastocytosis is the most common form of mastocytosis diagnosed in adults, characterized by mast cell infiltration of one or more extracutaneous organs (with or without skin involvement). […] The management of patients with mastocytosis requires a multidisciplinary team approach (involving dermatologists, hematologists, gastroenterologists, pathologists, and allergists/immunologists) preferably in specialized medical centers with expertise in the treatment of patients with mast cell disorders. […] These NCCN Guidelines provide recommendations for the diagnosis and management of patients with SM. Management of CM is not included in these guidelines. Referral to centers with expertise in CM is strongly recommended.

• #8 Systemic mastocytosis – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/care-at-mayo-clinic/mac-20352862

  Mayo Clinic doctors from several medical specialties work together to provide you with the best care possible. Your team may include specialists in allergic diseases, hematology, dermatology, gastroenterology, pediatrics, neurology, endocrinology and pathology. […] Your health care team will help you identify particular factors that may trigger your symptoms of systemic mastocytosis and work with you to help keep your symptoms under control. […] At Mayo Clinic, doctors manage systemic mastocytosis by regularly monitoring your condition, then tailoring a treatment plan to help you manage your specific symptoms. […] Mayo Clinic is one of the only centers to offer a special home kit that you can use to collect blood and urine samples while you’re experiencing symptoms, which gives your doctor a better picture of how systemic mastocytosis affects your body. […] Mayo Clinic doctors have experience diagnosing and caring for people with all types of systemic mastocytosis.

• #9 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Referral to specialized centers with expertise in the management of mastocytosis is strongly recommended. […] Patients should be counseled about the signs and symptoms of mast cell activation and the importance of avoiding known triggers of mast cell activation. Anaphylactic reactions are significantly more frequent in patients with ISM and should be managed with the use of epinephrine injection. All patients should carry 2 auto injectors of epinephrine to manage anaphylaxis. […] Anti-mediator drug therapy for mast cell activation symptoms (as described in next section) is recommended for all patients with SM. […] Cytoreductive therapy (discussed in next section) is recommended for patients with advanced SM (ASM, SM-AHN, and MCL) because of the frequent presence of organ damage and shortened survival of this patient population. […] Enrollment in well-designed clinical trials investigating novel therapeutic strategies (eg, selective KIT D816 inhibitors) is encouraged to enable further advances.

• #10 Mastocytosis Center – Brigham and Women’s Hospital

  https://www.brighamandwomens.org/medicine/allergy-clinical-immunology/allergy-mastocytosis-center?TRILIBIS_EMULATOR_UA=…%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%2Cgm%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn

  The Mastocytosis Center provides care for adults and children with mast cell activation disorders. This includes cutaneous mastocytosis, systemic mastocytosis, mast cell activation syndromes, idiopathic anaphylaxis, and hereditary alpha tryptasemia. […] We are able to care for complex patients through our extensive care team consisting of more than ten physicians in eight different medical specialties. […] We have developed treatment innovations such as the first ultra-rush venom desensitization protocol for patients with mastocytosis and life-threatening anaphylaxis to hymenoptera venom. […] Patients seen at the Mastocytosis Center are eligible to participate in ongoing clinical and/or translational research.

• #11 Mastocytosis Treatment & Management: Medical Care, Consultations, Diet

  https://emedicine.medscape.com/article/1057932-treatment

  Medical alert bracelets should be made available, and an epinephrine self-injector demonstration should be performed and self-injector prescribed for patients with systemic mastocytosis or patients with episodes of vascular collapse. Patients with recurrent episodes of vascular collapse may be prophylactically placed on H1 and H2 antihistamines to lessen the severity of attacks. […] General anesthesia may be problematic in patients with systemic mastocytosis and perioperative modalities of these patients need to be considered. […] The treatment algorithm for systemic mastocytosis is complex, and the condition is primarily managed by a hematologist. […] Consultation with a hematologist may be necessary for a bone marrow biopsy and staging. […] Traditionally, physicians have advised cutaneous mastocytosis patients to avoid substances that induce mast cell mediator release, such as salicylates, crawfish, lobster, alcohol, spicy foods, hot beverages, and cheese. […] Advise cutaneous mastocytosis patients to avoid certain physical stimuli, including emotional stress, temperature extremes, physical exertion, bacterial toxins, envenomation by insects to which the patient is allergic, and rubbing, scratching, or traumatizing the lesions of cutaneous mastocytosis.

• #12 Mastocytosis: Types, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/5908-mastocytosis

  Mastocytosis is an incurable disease. Different types of mastocytosis affect people in different ways. If youre living with mastocytosis, here are some general suggestions that may help: […] You’ll have regular checkups with your healthcare provider so they can monitor your symptoms and, if needed, adjust your treatment. Contact your provider any time you notice new symptoms or your symptoms are worse. […] Mastocytosis is a rare condition that happens when your body makes abnormal mast cells that multiply uncontrollably, affecting your skin and organs. Most people with mastocytosis manage its symptoms by knowing what triggers mastocytosis and by taking medication. People with this condition should also have self-injecting syringes of epinephrine at hand to treat severe allergic reactions. […] Cleveland Clinic can help you manage that with personalized treatment.

• #13 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis care at Mayo Clinic. […] Our caring team of Mayo Clinic experts can help you with your systemic mastocytosis-related health concerns. […] Treatment may vary, depending on the type of systemic mastocytosis and the body organs affected. Treatment generally includes controlling symptoms, treating the disease and regular monitoring. […] Identifying and avoiding factors that may trigger your mast cells, such as certain foods, medications or insect stings, can help keep your systemic mastocytosis symptoms under control. […] A health care professional can teach you how to give yourself an epinephrine injection in the event that you have a severe allergic response when your mast cells are triggered. […] Your doctor regularly monitors the status of your condition using blood and urine samples.

• #14 Systemic mastocytosis – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/care-at-mayo-clinic/mac-20352862

  Mayo Clinic doctors from several medical specialties work together to provide you with the best care possible. Your team may include specialists in allergic diseases, hematology, dermatology, gastroenterology, pediatrics, neurology, endocrinology and pathology. […] Your health care team will help you identify particular factors that may trigger your symptoms of systemic mastocytosis and work with you to help keep your symptoms under control. […] At Mayo Clinic, doctors manage systemic mastocytosis by regularly monitoring your condition, then tailoring a treatment plan to help you manage your specific symptoms. […] Mayo Clinic is one of the only centers to offer a special home kit that you can use to collect blood and urine samples while you’re experiencing symptoms, which gives your doctor a better picture of how systemic mastocytosis affects your body. […] Mayo Clinic doctors have experience diagnosing and caring for people with all types of systemic mastocytosis.

• #15 Mastocytosis Center – Brigham and Women’s Hospital

  https://www.brighamandwomens.org/medicine/allergy-clinical-immunology/allergy-mastocytosis-center?TRILIBIS_EMULATOR_UA=…%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%2Cgm%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn

  The Mastocytosis Center provides care for adults and children with mast cell activation disorders. This includes cutaneous mastocytosis, systemic mastocytosis, mast cell activation syndromes, idiopathic anaphylaxis, and hereditary alpha tryptasemia. […] We are able to care for complex patients through our extensive care team consisting of more than ten physicians in eight different medical specialties. […] We have developed treatment innovations such as the first ultra-rush venom desensitization protocol for patients with mastocytosis and life-threatening anaphylaxis to hymenoptera venom. […] Patients seen at the Mastocytosis Center are eligible to participate in ongoing clinical and/or translational research.

• #16 Duke Blood Cancer Center Named Mast Cell Diseases Center of Excellence | Duke Health

  https://www.dukehealth.org/blog/duke-blood-cancer-center-named-mast-cell-diseases-center-of-excellence

  The Duke Blood Cancer Center has been recognized as a Center of Excellence by the American Initiative in Mast Cell Diseases Network. This designation acknowledges the centers expertise in caring for people with systemic mastocytosis and related mast cell disorders. […] The Duke Blood Cancer Center is one of a handful of centers in the Southeast with the experience and capability to treat mast cell diseases. […] Having experts in multiple specialties — including hematology, allergy and immunology, dermatology, and oncology — is essential for helping people manage these symptoms, treating their disease, and improving their quality of life. […] In addition to patient care, Dr. Rein and her colleagues are actively involved in research on new treatments for systemic mastocytosis and other mast cell diseases. […] While there is currently no cure for systemic mastocytosis and related mast cell disorders, receiving comprehensive care at a Mast Cell Diseases Center of Excellence can help people with these conditions live a full and fulfilling life.

• #17 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Referral to specialized centers with expertise in the management of mastocytosis is strongly recommended. […] Patients should be counseled about the signs and symptoms of mast cell activation and the importance of avoiding known triggers of mast cell activation. Anaphylactic reactions are significantly more frequent in patients with ISM and should be managed with the use of epinephrine injection. All patients should carry 2 auto injectors of epinephrine to manage anaphylaxis. […] Anti-mediator drug therapy for mast cell activation symptoms (as described in next section) is recommended for all patients with SM. […] Cytoreductive therapy (discussed in next section) is recommended for patients with advanced SM (ASM, SM-AHN, and MCL) because of the frequent presence of organ damage and shortened survival of this patient population. […] Enrollment in well-designed clinical trials investigating novel therapeutic strategies (eg, selective KIT D816 inhibitors) is encouraged to enable further advances.

• #18 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #19 Mastocytosis: Types, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/5908-mastocytosis

  Most people can manage mastocytosis symptoms with medication and by avoiding activities and environments that trigger the condition. […] Healthcare providers cant cure mastocytosis, but they can treat its symptoms and the complications the condition causes. […] Treatment varies based on mastocytosis type and your symptoms. In general, providers use medications and other treatments to ease symptoms. […] Providers may use a variety of treatments for mastocytosis symptoms. Most treatments have side effects, some more serious than others. If you have mastocytosis, your provider will explain what you can expect, including treatment side effects. […] If you have systemic mastocytosis, you should always carry a self-injecting syringe of epinephrine, a hormone made by adrenal glands. Epinephrine treats severe allergic reactions that could become life-threatening anaphylactic shock.

• #20

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  If symptoms such as itchiness are particularly severe, corticosteroid tablets (oral corticosteroids) may be prescribed on a short-term basis. […] If you have weakened bones (osteoporosis) resulting from abnormal mast cell activity in your bones, you’ll be given a medicine called bisphosphonates. […] Interferon alpha has proved effective in treating some cases of aggressive mastocytosis. […] Imatinib is an alternative medicine to interferon alpha. […] Nilotinib or dasatinib may be recommended if you do not respond to treatment with imatinib. […] Midostaurin is a licensed medicine that can be used to treat advanced systemic mastocytosis. […] Cladribine is an alternative medicine to midostaurin. […] Avapritinib is a medicine that can be used to treat advanced systemic mastocytosis in adults. […] Because of your increased risk of anaphylaxis, you may be given an adrenaline auto-injector to use in an emergency.

• #21 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis can be a complex disease. Understanding your condition is critical to ongoing care and prevention of complications. […] Follow your doctor’s recommended care and ongoing monitoring. […] Caring for a lifelong disorder such as systemic mastocytosis can be stressful and exhausting. […] You’ll need to make important decisions about care. Medical centers with specialty teams can offer you information about systemic mastocytosis, as well as advice and support, and can help you manage care. […] Ask for or accept help from family and friends when needed. Take time for your interests and activities. Counseling with a mental health professional may help with adjustment and coping.

• #22 Systemic Mastocytosis: 6 Healthy Habits

  https://www.healthline.com/health/allergies/systemic-mastocytosis-healthy-habits

  Systemic mastocytosis is rare, so you may not find a dedicated support group in your area. […] Theres no cure for systemic mastocytosis. But treatment can reduce the effects of the disease and control symptoms. Avoiding triggers is key to living well with mastocytosis. […] In addition to following your treatment plan, following these six healthy habits can help you avoid potential triggers and better manage life with systemic mastocytosis.

• #23 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #24 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis care at Mayo Clinic. […] Our caring team of Mayo Clinic experts can help you with your systemic mastocytosis-related health concerns. […] Treatment may vary, depending on the type of systemic mastocytosis and the body organs affected. Treatment generally includes controlling symptoms, treating the disease and regular monitoring. […] Identifying and avoiding factors that may trigger your mast cells, such as certain foods, medications or insect stings, can help keep your systemic mastocytosis symptoms under control. […] A health care professional can teach you how to give yourself an epinephrine injection in the event that you have a severe allergic response when your mast cells are triggered. […] Your doctor regularly monitors the status of your condition using blood and urine samples.

• #25 Mastocytosis Treatment & Management: Medical Care, Consultations, Diet

  https://emedicine.medscape.com/article/1057932-treatment

  Therapy is conservative and aimed at symptom relief because the prognosis for most patients with cutaneous mastocytosis (CM) is excellent. None of the currently available therapeutic measures induces permanent involution of cutaneous or visceral lesions. Advise patients to avoid agents that precipitate mediator release, such as aspirin, nonsteroidal anti-inflammatory drugs, codeine, morphine, alcohol, thiamine, quinine, opiates, gallamine, decamethonium, procaine, radiographic dyes, dextran, polymyxin B, scopolamine, and D-tubocurarine. […] H1 and H2 antihistamines decrease pruritus, flushing, and GI symptoms. Oral disodium cromoglycate may ameliorate cutaneous symptoms, such as pruritus, whealing, and flushing, as well as systemic symptoms, such as diarrhea, abdominal pain, bone pain, and disorders of cognitive function.

• #26 Mastocytosis Treatment & Management: Medical Care, Consultations, Diet

  https://emedicine.medscape.com/article/1057932-treatment

  Medical alert bracelets should be made available, and an epinephrine self-injector demonstration should be performed and self-injector prescribed for patients with systemic mastocytosis or patients with episodes of vascular collapse. Patients with recurrent episodes of vascular collapse may be prophylactically placed on H1 and H2 antihistamines to lessen the severity of attacks. […] General anesthesia may be problematic in patients with systemic mastocytosis and perioperative modalities of these patients need to be considered. […] The treatment algorithm for systemic mastocytosis is complex, and the condition is primarily managed by a hematologist. […] Consultation with a hematologist may be necessary for a bone marrow biopsy and staging. […] Traditionally, physicians have advised cutaneous mastocytosis patients to avoid substances that induce mast cell mediator release, such as salicylates, crawfish, lobster, alcohol, spicy foods, hot beverages, and cheese. […] Advise cutaneous mastocytosis patients to avoid certain physical stimuli, including emotional stress, temperature extremes, physical exertion, bacterial toxins, envenomation by insects to which the patient is allergic, and rubbing, scratching, or traumatizing the lesions of cutaneous mastocytosis.

• #27 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  Not all mast cell disease patients have foods that trigger them, but many do. […] Mast cells can be triggered by extreme temperatures and by changes in temperature. […] Patients are often triggered by the smell of cleaning chemicals and perfumes. […] Some mast cell patients can tolerate drinking alcohol, but many cannot. […] Mast Cell Disease can be frustrating because it is unpredictable. […] We all know that exercise helps keep our bodies healthy and strong. […] If you have lesions from mastocytosis, or tend toward hives with your MCD, one thing you can do to minimize irritation and itching is to have good regular skin care.

• #28 Systemic Mastocytosis: Causes, Symptoms, Diagnosis, and Treatment

  https://www.webmd.com/allergies/systemic-mastocytosis

  Systemic mastocytosis is a disease where too many abnormal mast cells (a type of white blood cell) build up in your skin and other organs. […] There’s no cure, but treatments can help you manage the condition. […] Consider reaching out to family and friends for support as you manage this disease. They can help you deal with the emotions and stress that come with the challenges of a long-term condition like systemic mastocytosis. […] One of the best ways to manage systemic mastocytosis is to avoid triggers. You’ll want to talk to your doctor and keep track of all the things that cause your symptoms, such as stress or spicy food. […] Because the disease can cause a life-threatening allergic reaction, you’ll also want to carry an epinephrine auto-injector at all times. […] Whatever type you have, after your diagnosis, you’ll go to regular follow-up appointments with your doctor. They’ll track your disease and check that your treatments are working. […] If you find that the challenges of managing your disease are making you depressed or anxious, talk to your doctor. They can put you in touch with mental health professionals who are experts in treating these problems.

• #29 Mastocytosis: Types, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/5908-mastocytosis

  Most people can manage mastocytosis symptoms with medication and by avoiding activities and environments that trigger the condition. […] Healthcare providers cant cure mastocytosis, but they can treat its symptoms and the complications the condition causes. […] Treatment varies based on mastocytosis type and your symptoms. In general, providers use medications and other treatments to ease symptoms. […] Providers may use a variety of treatments for mastocytosis symptoms. Most treatments have side effects, some more serious than others. If you have mastocytosis, your provider will explain what you can expect, including treatment side effects. […] If you have systemic mastocytosis, you should always carry a self-injecting syringe of epinephrine, a hormone made by adrenal glands. Epinephrine treats severe allergic reactions that could become life-threatening anaphylactic shock.

• #30

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  If symptoms such as itchiness are particularly severe, corticosteroid tablets (oral corticosteroids) may be prescribed on a short-term basis. […] If you have weakened bones (osteoporosis) resulting from abnormal mast cell activity in your bones, you’ll be given a medicine called bisphosphonates. […] Interferon alpha has proved effective in treating some cases of aggressive mastocytosis. […] Imatinib is an alternative medicine to interferon alpha. […] Nilotinib or dasatinib may be recommended if you do not respond to treatment with imatinib. […] Midostaurin is a licensed medicine that can be used to treat advanced systemic mastocytosis. […] Cladribine is an alternative medicine to midostaurin. […] Avapritinib is a medicine that can be used to treat advanced systemic mastocytosis in adults. […] Because of your increased risk of anaphylaxis, you may be given an adrenaline auto-injector to use in an emergency.

• #31 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #32 Mastocytosis

  https://www.pcds.org.uk/clinical-guidance/mastocytosis

  Up to 50% of adults and 20% of children experience one or more episodes of anaphylaxis so patients should be provided with Epipens and taught how to use them. […] Reduce exposure to triggers that cause mast-cell destabilisation such as physical triggers (especially rubbing, heat or exertion), alcohol, nonsteroidal anti-inflammatory drugs (eg aspirin, ibuprofen, diclofenac), various general anaesthetic drugs – patients must be made aware of this, opiates, insect and snake venoms, other allergens eg latex. […] Medical treatment is generally disappointing. […] Phototherapy has been used to try and improve the appearance of maculopapular cutaneous mastocytosis, but for many, improvement will be minimal. […] Antihistamines, sometimes at high doses, may be used for itch, but again often lack efficacy.

• #33 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Patients with severe GI symptoms may need endoscopic procedures and biopsies to exclude other causes of malabsorption. […] Insect stings can precipitate anaphylaxis; therefore, patients with systemic mastocytosis should exercise great care in avoiding stings when engaging in outdoor activities. […] Patients should carry an epinephrine autoinjector at all times and should be taught to use the device in case of emergency.

• #34 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #35 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Therapy for systemic mastocytosis (systemic mast cell disease) is primarily symptomatic; no therapy is curative. Treatment modalities include the management of (1) anaphylaxis and related symptoms, (2) pruritus and flushing, and (3) intestinal malabsorption. The principles of treatment include control of symptoms with measures to decrease mast cell activation. […] Antihistamines (H1 and H2 receptor blockers) are part of initial pharmacologic treatment in systemic mastocytosis. […] Cromolyn sodium has demonstrated multiple benefits in systemic mastocytosis. It has proved useful for relieving abdominal pain and diarrhea; pruritus, whealing, and flushing; and impaired cognition. […] Corticosteroids have been used to control malabsorption, ascites, abdominal pain refractory to cromolyn, bone pain, and diffuse cutaneous disease refractory to topical therapy, and to prevent anaphylaxis.

• #36

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  The treatment options for mastocytosis depend on which type you have and how severe your symptoms are. […] Nearly all medicines used to treat mastocytosis are unlicensed. […] Many experts will use an unlicensed medicine if they think it will be effective and the benefits of treatment outweigh any associated risk. […] Mild to moderate cases of cutaneous mastocytosis can be treated with a very strong steroid cream (topical corticosteroids) for a limited length of time. […] Antihistamines can also be used to treat symptoms of cutaneous or indolent mastocytosis, such as itchiness and skin redness. […] Sodium cromoglicate is a mast cell stabiliser, which means it reduces the amount of chemicals released by the mast cells. […] More severe symptoms of cutaneous mastocytosis, such as severe itchy skin, may require a type of treatment called psoralen plus ultraviolet A (PUVA).

• #37

  https://www.nhs.uk/conditions/mastocytosis/

  There’s no cure for mastocytosis, so the aim of treatment is to try to relieve the symptoms. […] Treatment options will depend on the type of mastocytosis and the severity of the symptoms. […] Mild to moderate cases of cutaneous mastocytosis can be treated with steroid cream (topical corticosteroids) for a short time. […] Steroid cream reduces the number of mast cells that can release histamine and trigger swelling (inflammation) in the skin. […] Antihistamines can also be used to treat the symptoms of cutaneous or indolent mastocytosis, such as red skin and itchiness. […] Antihistamines are a type of medicine that block the effects of histamine and are often used to treat allergic conditions.

• #38 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Therapy for systemic mastocytosis (systemic mast cell disease) is primarily symptomatic; no therapy is curative. Treatment modalities include the management of (1) anaphylaxis and related symptoms, (2) pruritus and flushing, and (3) intestinal malabsorption. The principles of treatment include control of symptoms with measures to decrease mast cell activation. […] Antihistamines (H1 and H2 receptor blockers) are part of initial pharmacologic treatment in systemic mastocytosis. […] Cromolyn sodium has demonstrated multiple benefits in systemic mastocytosis. It has proved useful for relieving abdominal pain and diarrhea; pruritus, whealing, and flushing; and impaired cognition. […] Corticosteroids have been used to control malabsorption, ascites, abdominal pain refractory to cromolyn, bone pain, and diffuse cutaneous disease refractory to topical therapy, and to prevent anaphylaxis.

• #39

  https://www.nhs.uk/conditions/mastocytosis/

  There’s no cure for mastocytosis, so the aim of treatment is to try to relieve the symptoms. […] Treatment options will depend on the type of mastocytosis and the severity of the symptoms. […] Mild to moderate cases of cutaneous mastocytosis can be treated with steroid cream (topical corticosteroids) for a short time. […] Steroid cream reduces the number of mast cells that can release histamine and trigger swelling (inflammation) in the skin. […] Antihistamines can also be used to treat the symptoms of cutaneous or indolent mastocytosis, such as red skin and itchiness. […] Antihistamines are a type of medicine that block the effects of histamine and are often used to treat allergic conditions.

• #40 Mastocytosis Treatment & Management: Medical Care, Consultations, Diet

  https://emedicine.medscape.com/article/1057932-treatment

  Therapy is conservative and aimed at symptom relief because the prognosis for most patients with cutaneous mastocytosis (CM) is excellent. None of the currently available therapeutic measures induces permanent involution of cutaneous or visceral lesions. Advise patients to avoid agents that precipitate mediator release, such as aspirin, nonsteroidal anti-inflammatory drugs, codeine, morphine, alcohol, thiamine, quinine, opiates, gallamine, decamethonium, procaine, radiographic dyes, dextran, polymyxin B, scopolamine, and D-tubocurarine. […] H1 and H2 antihistamines decrease pruritus, flushing, and GI symptoms. Oral disodium cromoglycate may ameliorate cutaneous symptoms, such as pruritus, whealing, and flushing, as well as systemic symptoms, such as diarrhea, abdominal pain, bone pain, and disorders of cognitive function.

• #41 Cutaneous and Systemic Manifestations of Mastocytosis | AAFP

  https://www.aafp.org/pubs/afp/issues/1999/0601/p3047.html

  Histamine H1 antagonists are used to treat the pruritus, flushing, bullae and urticaria. […] Histamine H2 blockers can be used to decrease the gastric hyperacidity that often accompanies concomitant ulcer disease in patients with systemic mastocytosis. […] Both H1 and H2 blockers should be used to treat anaphylaxis. […] Systemic steroids may be necessary to control the severe skin disease, malabsorption or ascites of systemic mastocytosis.

• #42 What are treatments for Systemic Mastocytosis? – HealthTree for Systemic Mastocytosis

  https://healthtree.org/mastocytosis/community/what-are-treatments-for-systemic-mastocytosis

  Antihistamines, such as cetirizine and loratadine, help manage skin symptoms like flushing and itching, as well as gastrointestinal issues like stomach pain, heartburn, cramping, and diarrhea. […] Mast cell stabilizers, such as cromolyn sodium, prevent mast cells from releasing harmful substances, helping with allergy-like symptoms like rash, itching, and eye inflammation. […] Injectable epinephrine is sometimes needed if patients experience a full-body allergic reaction called anaphylaxis. […] Monoclonal antibodies such as omalizumab (anti-IgE) can reduce the frequency of anaphylaxis. […] Steroids such as prednisone reduce inflammation and have been used to control gastrointestinal issues like malabsorption, fluid build-up in the abdomen, stomach pain, bone pain, and skin disease that doesn’t respond to topical treatment. Steroids can also be used to prevent anaphylaxis.

• #43 Mastocytosis (Mast Cell Disorder): Symptoms and Treatment

  https://patient.info/doctor/mastocytosis-and-mast-cell-disorders

  Mastocytosis treatment and management is concerned mainly with symptom control, as there is currently no cure. Systemic mastocytosis is usually managed by haematologists. […] For pruritus, weals and flushing – H1 and H2 receptor antagonists such as chlorphenamine, ketotifen and cimetidine. […] There is some evidence that long-term use of antihistamines can affect cognition, so these drugs should be titrated to the lowest effective dose and used for the shortest possible time. […] Local corticosteroids for skin lesions. Intralesional steroid injection is sometimes used. […] Patients with recurrent anaphylactoid reactions should carry injectable adrenaline (epinephrine) in pen format for emergency use. […] Acute anaphylaxis is treated with intramuscular adrenaline (epinephrine), antihistamines (H1 and H2 receptor blockers), fluids and pressor agents. […] Guidelines for management in children are available.

• #44 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  Antihistamines can help by alleviating symptoms triggered by the release of histamine, such as itching, welting, flushing, gastrointestinal discomfort, as well as respiratory, sinus and airway symptoms. […] People with mastocytosis often carry a syringe of epinephrine, a hormone made by the adrenal glands, in case they need to treat a severe allergic reaction. […] Designed to inhibit the excessive release of chemicals from mast cells, which may assist with symptoms such as itching, hives, skin flushing and gastrointestinal issues. […] Can aid in the management of symptoms such as breathing difficulties, skin rashes, gastrointestinal issues and overall mast cell stability (all mast cell activation symptoms). […] Topical corticosteroids may be used for the treatment of cutaneous disease and may be used to reduce the size of skin lesions.

• #45 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Therapy for systemic mastocytosis (systemic mast cell disease) is primarily symptomatic; no therapy is curative. Treatment modalities include the management of (1) anaphylaxis and related symptoms, (2) pruritus and flushing, and (3) intestinal malabsorption. The principles of treatment include control of symptoms with measures to decrease mast cell activation. […] Antihistamines (H1 and H2 receptor blockers) are part of initial pharmacologic treatment in systemic mastocytosis. […] Cromolyn sodium has demonstrated multiple benefits in systemic mastocytosis. It has proved useful for relieving abdominal pain and diarrhea; pruritus, whealing, and flushing; and impaired cognition. […] Corticosteroids have been used to control malabsorption, ascites, abdominal pain refractory to cromolyn, bone pain, and diffuse cutaneous disease refractory to topical therapy, and to prevent anaphylaxis.

• #46

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  The treatment options for mastocytosis depend on which type you have and how severe your symptoms are. […] Nearly all medicines used to treat mastocytosis are unlicensed. […] Many experts will use an unlicensed medicine if they think it will be effective and the benefits of treatment outweigh any associated risk. […] Mild to moderate cases of cutaneous mastocytosis can be treated with a very strong steroid cream (topical corticosteroids) for a limited length of time. […] Antihistamines can also be used to treat symptoms of cutaneous or indolent mastocytosis, such as itchiness and skin redness. […] Sodium cromoglicate is a mast cell stabiliser, which means it reduces the amount of chemicals released by the mast cells. […] More severe symptoms of cutaneous mastocytosis, such as severe itchy skin, may require a type of treatment called psoralen plus ultraviolet A (PUVA).

• #47

  https://www.nhs.uk/conditions/mastocytosis/

  There’s no cure for mastocytosis, so the aim of treatment is to try to relieve the symptoms. […] Treatment options will depend on the type of mastocytosis and the severity of the symptoms. […] Mild to moderate cases of cutaneous mastocytosis can be treated with steroid cream (topical corticosteroids) for a short time. […] Steroid cream reduces the number of mast cells that can release histamine and trigger swelling (inflammation) in the skin. […] Antihistamines can also be used to treat the symptoms of cutaneous or indolent mastocytosis, such as red skin and itchiness. […] Antihistamines are a type of medicine that block the effects of histamine and are often used to treat allergic conditions.

• #48

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  If symptoms such as itchiness are particularly severe, corticosteroid tablets (oral corticosteroids) may be prescribed on a short-term basis. […] If you have weakened bones (osteoporosis) resulting from abnormal mast cell activity in your bones, you’ll be given a medicine called bisphosphonates. […] Interferon alpha has proved effective in treating some cases of aggressive mastocytosis. […] Imatinib is an alternative medicine to interferon alpha. […] Nilotinib or dasatinib may be recommended if you do not respond to treatment with imatinib. […] Midostaurin is a licensed medicine that can be used to treat advanced systemic mastocytosis. […] Cladribine is an alternative medicine to midostaurin. […] Avapritinib is a medicine that can be used to treat advanced systemic mastocytosis in adults. […] Because of your increased risk of anaphylaxis, you may be given an adrenaline auto-injector to use in an emergency.

• #49

  https://www.nhs.uk/conditions/mastocytosis/

  There’s no cure for mastocytosis, so the aim of treatment is to try to relieve the symptoms. […] Treatment options will depend on the type of mastocytosis and the severity of the symptoms. […] Mild to moderate cases of cutaneous mastocytosis can be treated with steroid cream (topical corticosteroids) for a short time. […] Steroid cream reduces the number of mast cells that can release histamine and trigger swelling (inflammation) in the skin. […] Antihistamines can also be used to treat the symptoms of cutaneous or indolent mastocytosis, such as red skin and itchiness. […] Antihistamines are a type of medicine that block the effects of histamine and are often used to treat allergic conditions.

• #50 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Therapy for systemic mastocytosis (systemic mast cell disease) is primarily symptomatic; no therapy is curative. Treatment modalities include the management of (1) anaphylaxis and related symptoms, (2) pruritus and flushing, and (3) intestinal malabsorption. The principles of treatment include control of symptoms with measures to decrease mast cell activation. […] Antihistamines (H1 and H2 receptor blockers) are part of initial pharmacologic treatment in systemic mastocytosis. […] Cromolyn sodium has demonstrated multiple benefits in systemic mastocytosis. It has proved useful for relieving abdominal pain and diarrhea; pruritus, whealing, and flushing; and impaired cognition. […] Corticosteroids have been used to control malabsorption, ascites, abdominal pain refractory to cromolyn, bone pain, and diffuse cutaneous disease refractory to topical therapy, and to prevent anaphylaxis.

• #51 What are treatments for Systemic Mastocytosis? – HealthTree for Systemic Mastocytosis

  https://healthtree.org/mastocytosis/community/what-are-treatments-for-systemic-mastocytosis

  Antihistamines, such as cetirizine and loratadine, help manage skin symptoms like flushing and itching, as well as gastrointestinal issues like stomach pain, heartburn, cramping, and diarrhea. […] Mast cell stabilizers, such as cromolyn sodium, prevent mast cells from releasing harmful substances, helping with allergy-like symptoms like rash, itching, and eye inflammation. […] Injectable epinephrine is sometimes needed if patients experience a full-body allergic reaction called anaphylaxis. […] Monoclonal antibodies such as omalizumab (anti-IgE) can reduce the frequency of anaphylaxis. […] Steroids such as prednisone reduce inflammation and have been used to control gastrointestinal issues like malabsorption, fluid build-up in the abdomen, stomach pain, bone pain, and skin disease that doesn’t respond to topical treatment. Steroids can also be used to prevent anaphylaxis.

• #52 Systemic Mastocytosis Treatment & Management: Medical Care, Surgical Care, Consultations

  https://emedicine.medscape.com/article/203948-treatment

  Osteoporotic fractures are common in patients with mastocytosis. […] Antiresorptive treatment with bisphosphonates is a rational treatment for osteoporosis in patients with systemic mastocytosis. […] Medical therapy for systemic mastocytosis is generally considered as initial treatment for patients with advanced systemic mastocytosis (aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, mast cell leukemia), as bridging treatment to undergo allogenic hematopoietic cell transplantation, or in selected patients with indolent systemic mastocytosis or smoldering systemic mastocytosis who suffer recurrent anaphylaxis despite treatment with all other options. […] Patients thought to have severe systemic mastocytosis that requires chemotherapy may need consultation with hematologists, dermatologists, and immunologists.

• #53 Rare diseases | Systemic Mastocytosis

  https://www.istitutogentili.com/en/rare-diseases/systemic-mastocytosis/

  Treatment options currently available can be classified into: anti-mediator therapy to reduce the release or the effects of mast cell mediators, cytoreduction therapies to reduce the mast cell burden. […] Therapeutic options available for advanced systemic mastocytosis include: c-KIT receptor inhibitors, chemotherapeutics, anti-inflammatory therapy, supportive therapy for the symptoms.

• #54

  https://www.nhs.uk/conditions/mastocytosis/treatment/

  If symptoms such as itchiness are particularly severe, corticosteroid tablets (oral corticosteroids) may be prescribed on a short-term basis. […] If you have weakened bones (osteoporosis) resulting from abnormal mast cell activity in your bones, you’ll be given a medicine called bisphosphonates. […] Interferon alpha has proved effective in treating some cases of aggressive mastocytosis. […] Imatinib is an alternative medicine to interferon alpha. […] Nilotinib or dasatinib may be recommended if you do not respond to treatment with imatinib. […] Midostaurin is a licensed medicine that can be used to treat advanced systemic mastocytosis. […] Cladribine is an alternative medicine to midostaurin. […] Avapritinib is a medicine that can be used to treat advanced systemic mastocytosis in adults. […] Because of your increased risk of anaphylaxis, you may be given an adrenaline auto-injector to use in an emergency.

• #55 Leukemia and Other Blood Cancers: Systemic Mastocytosis | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/leukemias/types/systemic-mastocytosis

  Mastocytosis happens when too many mast cells build up in the body. Mast cells are a type of white blood cell that play an important role in helping the immune system defend the body from disease. They also respond to allergic reactions, help heal wounds, and defend against infections. […] In systemic mastocytosis, however, there are too many mast cells throughout the body, including in the gastrointestinal tract and the bone marrow. When the disease is in the intestinal tract, it can lead to nausea, vomiting, diarrhea, and abdominal pain. […] Our doctors typically treat the illness with antihistamines, drugs that are used for people with allergies. For more severe cases, we may recommend steroid or chemotherapy treatment. A targeted drug called midostaurin (Rydapt) is approved to treat more-aggressive cases of systemic mastocytosis. Finally, our scientists are researching new drugs for people with systemic mastocytosis that carries certain mutations.

• #56 Mastocytosis: What is It and How Is It Treated? | Dana-Farber Cancer Institute

  https://blog.dana-farber.org/insight/2017/12/mastocytosis-treatment/

  Mastocytosis is a rare type of mast cell disorder characterized by the abnormal accumulation of mast cells in various organ systems such as the skin, liver, spleen, intestine, or bone marrow. […] Systemic mastocytosis is diagnosed through a bone marrow aspiration and biopsy and may involve care by a hematologist/oncologist. […] These aggressive forms of systemic mastocytosis or mast cell leukemia are generally treated with chemotherapy. […] In June 2021, the U.S. Food and Drug Administration approved a precision drug, avapritinib (Ayvakit), to treat aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia. […] Since avapritinib is able to selectively target the primary driver of the disease, it has the potential to fundamentally change the outlook for patients with advanced systemic mastocytosis. […] Learn more about treatment for blood disorders from the Hematologic Oncology Treatment Center at Dana-Farber/Brigham and Womens Cancer Center.

• #57 Quest to find better treatments for rare blood cancer leads to new therapies | News Center

  https://med.stanford.edu/news/all-news/2022/03/systemic-mastocytosis-therapies.html

  „Overall, her quality of life was quite poor,” Gotlib said. […] Although a medication called imatinib, which is sold under the brand name Gleevec, has been approved for use in advanced SM, it is ineffective against the D816V mutation (although it may be useful in the rare SM patients who have normal KIT or other mutations in the gene). […] „Avapritinib is considerably more selective than midostaurin,” Gotlib said. „It was specifically designed to inhibit the KIT D816V mutation with very few other targets. Midostaurin was a big step forward in the treatment of advanced SM, but it hits several other targets, and avapritinib is more potent.” […] Of the 53 patients with advanced SM evaluated in the EXPLORER trial, 75% experienced at least some benefit from the drug and 36% of patients experienced a complete remission. The drug is not without side effects, which may include facial swelling, diarrhea, nausea and fatigue. There is also a risk of intracranial bleeding in people with low platelet counts.

• #58 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #59 Mastocytosis: Types, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/5908-mastocytosis

  Most people can manage mastocytosis symptoms with medication and by avoiding activities and environments that trigger the condition. […] Healthcare providers cant cure mastocytosis, but they can treat its symptoms and the complications the condition causes. […] Treatment varies based on mastocytosis type and your symptoms. In general, providers use medications and other treatments to ease symptoms. […] Providers may use a variety of treatments for mastocytosis symptoms. Most treatments have side effects, some more serious than others. If you have mastocytosis, your provider will explain what you can expect, including treatment side effects. […] If you have systemic mastocytosis, you should always carry a self-injecting syringe of epinephrine, a hormone made by adrenal glands. Epinephrine treats severe allergic reactions that could become life-threatening anaphylactic shock.

• #60 Systemic Mastocytosis: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/24386-systemic-mastocytosis

  Healthcare providers cant cure the condition. But treatment can ease your symptoms. […] Healthcare providers treat systemic mastocytosis by managing symptoms and complications. For example, if you have excess stomach acid, they may prescribe H2 blockers (antacids). If the condition causes anemia, theyll treat the anemia. […] If you have systemic mastocytosis, you should always carry an EpiPen. Epinephrine treats anaphylactic shock, a severe, life-threatening allergic reaction. […] Knowing how to avoid triggers is a big part of living with systemic mastocytosis. If you have this condition, you should: Always carry an EpiPen to treat severe, life-threatening allergic reactions. […] Living with this condition is a big adjustment. Lean on your healthcare provider. Theyre here to help. They can point you to resources and support groups that can empower you to take control of your health.

• #61 Mastocytosis (Mast Cell Disorder): Symptoms and Treatment

  https://patient.info/doctor/mastocytosis-and-mast-cell-disorders

  Mastocytosis treatment and management is concerned mainly with symptom control, as there is currently no cure. Systemic mastocytosis is usually managed by haematologists. […] For pruritus, weals and flushing – H1 and H2 receptor antagonists such as chlorphenamine, ketotifen and cimetidine. […] There is some evidence that long-term use of antihistamines can affect cognition, so these drugs should be titrated to the lowest effective dose and used for the shortest possible time. […] Local corticosteroids for skin lesions. Intralesional steroid injection is sometimes used. […] Patients with recurrent anaphylactoid reactions should carry injectable adrenaline (epinephrine) in pen format for emergency use. […] Acute anaphylaxis is treated with intramuscular adrenaline (epinephrine), antihistamines (H1 and H2 receptor blockers), fluids and pressor agents. […] Guidelines for management in children are available.

• #62 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #63 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #64 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #65 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #66 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #67 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #68 Critical care management of systemic mastocytosis: when every wasp is a killer bee

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4453286/

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #69 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #70 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. […] The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. […] The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. […] For all patients with mastocytosis, epinephrine should be readily available as it hinders mast cell degranulation and is the first drug of choice during haemodynamic failure in these patients. […] It is important to realise that, during further ICU treatment, patients with mastocytosis are inevitably exposed to triggers of mast cell degranulation, which may be followed by severe anaphylactic responses.

• #71 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #72 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis can be a complex disease. Understanding your condition is critical to ongoing care and prevention of complications. […] Follow your doctor’s recommended care and ongoing monitoring. […] Caring for a lifelong disorder such as systemic mastocytosis can be stressful and exhausting. […] You’ll need to make important decisions about care. Medical centers with specialty teams can offer you information about systemic mastocytosis, as well as advice and support, and can help you manage care. […] Ask for or accept help from family and friends when needed. Take time for your interests and activities. Counseling with a mental health professional may help with adjustment and coping.

• #73 Systemic Mastocytosis: Causes, Symptoms, Diagnosis, and Treatment

  https://www.webmd.com/allergies/systemic-mastocytosis

  Systemic mastocytosis is a disease where too many abnormal mast cells (a type of white blood cell) build up in your skin and other organs. […] There’s no cure, but treatments can help you manage the condition. […] Consider reaching out to family and friends for support as you manage this disease. They can help you deal with the emotions and stress that come with the challenges of a long-term condition like systemic mastocytosis. […] One of the best ways to manage systemic mastocytosis is to avoid triggers. You’ll want to talk to your doctor and keep track of all the things that cause your symptoms, such as stress or spicy food. […] Because the disease can cause a life-threatening allergic reaction, you’ll also want to carry an epinephrine auto-injector at all times. […] Whatever type you have, after your diagnosis, you’ll go to regular follow-up appointments with your doctor. They’ll track your disease and check that your treatments are working. […] If you find that the challenges of managing your disease are making you depressed or anxious, talk to your doctor. They can put you in touch with mental health professionals who are experts in treating these problems.

• #74 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  Not all mast cell disease patients have foods that trigger them, but many do. […] Mast cells can be triggered by extreme temperatures and by changes in temperature. […] Patients are often triggered by the smell of cleaning chemicals and perfumes. […] Some mast cell patients can tolerate drinking alcohol, but many cannot. […] Mast Cell Disease can be frustrating because it is unpredictable. […] We all know that exercise helps keep our bodies healthy and strong. […] If you have lesions from mastocytosis, or tend toward hives with your MCD, one thing you can do to minimize irritation and itching is to have good regular skin care.

• #75 How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis | Primary Health Care Research & Development | Cambridge Core

  https://www.cambridge.org/core/journals/primary-health-care-research-and-development/article/how-persons-with-systemic-mastocytosis-describe-the-time-between-symptom-onset-and-receiving-diagnosis/DEDD41F33697B668404799755237327F

  The aim of the study was to explore how persons with systemic mastocytosis (SM) described the time between the onset of symptoms and signs and getting the diagnosis. […] The time between symptom and signs onset and diagnosis was perceived as difficult. SM often had a complex and unpredictable effect on a persons daily life, long before diagnosis. […] The study highlighted the importance of a person-centred approach and the need to increase knowledge of the disease within primary care, to shorten this stressful and vulnerable time. […] The participants described various symptoms and signs that had often appeared years before diagnosis. […] Most participants had experienced GI symptoms before diagnosis. […] The occurrence of attacks often resulted in vulnerable and exposed situations. This caused anxiety and fear, in part because the cause of the attacks was unknown.

• #76 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis can be a complex disease. Understanding your condition is critical to ongoing care and prevention of complications. […] Follow your doctor’s recommended care and ongoing monitoring. […] Caring for a lifelong disorder such as systemic mastocytosis can be stressful and exhausting. […] You’ll need to make important decisions about care. Medical centers with specialty teams can offer you information about systemic mastocytosis, as well as advice and support, and can help you manage care. […] Ask for or accept help from family and friends when needed. Take time for your interests and activities. Counseling with a mental health professional may help with adjustment and coping.

• #77 Systemic Mastocytosis: Causes, Symptoms, Diagnosis, and Treatment

  https://www.webmd.com/allergies/systemic-mastocytosis

  Systemic mastocytosis is a disease where too many abnormal mast cells (a type of white blood cell) build up in your skin and other organs. […] There’s no cure, but treatments can help you manage the condition. […] Consider reaching out to family and friends for support as you manage this disease. They can help you deal with the emotions and stress that come with the challenges of a long-term condition like systemic mastocytosis. […] One of the best ways to manage systemic mastocytosis is to avoid triggers. You’ll want to talk to your doctor and keep track of all the things that cause your symptoms, such as stress or spicy food. […] Because the disease can cause a life-threatening allergic reaction, you’ll also want to carry an epinephrine auto-injector at all times. […] Whatever type you have, after your diagnosis, you’ll go to regular follow-up appointments with your doctor. They’ll track your disease and check that your treatments are working. […] If you find that the challenges of managing your disease are making you depressed or anxious, talk to your doctor. They can put you in touch with mental health professionals who are experts in treating these problems.

• #78 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  While Mastocytosis and MCAS share some similarities in terms of symptom management, their distinct underlying causes, such as excessive mast cell proliferation and instability in mastocytosis, lead to different treatment approaches. Consequently, not all treatments suitable for Mastocytosis are safe or appropriate for MCAS, and some management strategies used for MCAS, such as rigid dietary restrictions, are also not always necessary or safe for individuals with Mastocytosis. […] The treatment of mastocytosis depends on the type, the symptoms of the disease, its extent and the person’s overall health. In many cases, different types of doctors often work together to create a patient’s overall treatment plan that combines different types of treatments. This is called multidisciplinary care.

• #79 Systemic mastocytosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478

  Systemic mastocytosis can be a complex disease. Understanding your condition is critical to ongoing care and prevention of complications. […] Follow your doctor’s recommended care and ongoing monitoring. […] Caring for a lifelong disorder such as systemic mastocytosis can be stressful and exhausting. […] You’ll need to make important decisions about care. Medical centers with specialty teams can offer you information about systemic mastocytosis, as well as advice and support, and can help you manage care. […] Ask for or accept help from family and friends when needed. Take time for your interests and activities. Counseling with a mental health professional may help with adjustment and coping.

• #80 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  There is no cure for mastocytosis, several treatments can be used to relieve symptoms. Take time to learn about all of your treatment options and be sure to ask questions about things that are unclear. Talk with your health care team about the goals of each treatment from a medical and individual (personal) perspective, ensuring quality of life goals are always supported. […] An important part of treating mastocytosis is controlling a person’s symptoms. One important way to do this is to avoid anything that may cause mast cells to release mediators like histamine, one of hundreds of mediators. This may include extreme temperatures, alcohol, emotional stress, insect bites and certain medications. […] Doctors may recommend the following treatments to help manage symptoms of mastocytosis.

• #81 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #82 Systemic Mastocytosis: 6 Healthy Habits

  https://www.healthline.com/health/allergies/systemic-mastocytosis-healthy-habits

  If you have systemic mastocytosis, you probably have a personalized treatment plan. You know how important it is to take medications as prescribed. […] But managing this condition takes more than medication. Living with mastocytosis means being on alert for potential triggers and taking steps to avoid them. […] Although triggers vary from person to person, some basic healthy habits may help as you navigate life with systemic mastocytosis. […] Stress is the most common trigger of mastocytosis. […] Foods are known triggers of anaphylaxis in people with mastocytosis. […] Two triggers that often go together are exercise and temperature changes. […] If you tend to have skin symptoms, such as rash, hives, or itching, give your skin a little extra care by: […] Living with a chronic condition can be challenging.

• #83 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #84 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #85 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  If your doctor has advised you to try a new medication to treat your mast cell disease, ask if you should start slowly. […] Patients diagnosed with any form of Systemic Mastocytosis qualify for free medications from NHS England because of its status as a neoplastic disease. […] Keep in mind that once youve read a few articles about mast cell disease, you have probably read more about it than your GP has. […] If you carry Epipens, bring them to your appointment and be sure youve taken your regular medications for your mast cell disease. […] If you are a regular visitor to the AE, talk with your consultant about preparing a protocol for what should be done there for you. […] Emotional stress can trigger mast cells to degranulate (release the chemicals stored inside them) and can be a direct trigger of a mast cell reaction.

• #86 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  Not all mast cell disease patients have foods that trigger them, but many do. […] Mast cells can be triggered by extreme temperatures and by changes in temperature. […] Patients are often triggered by the smell of cleaning chemicals and perfumes. […] Some mast cell patients can tolerate drinking alcohol, but many cannot. […] Mast Cell Disease can be frustrating because it is unpredictable. […] We all know that exercise helps keep our bodies healthy and strong. […] If you have lesions from mastocytosis, or tend toward hives with your MCD, one thing you can do to minimize irritation and itching is to have good regular skin care.

• #87 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  Not all mast cell disease patients have foods that trigger them, but many do. […] Mast cells can be triggered by extreme temperatures and by changes in temperature. […] Patients are often triggered by the smell of cleaning chemicals and perfumes. […] Some mast cell patients can tolerate drinking alcohol, but many cannot. […] Mast Cell Disease can be frustrating because it is unpredictable. […] We all know that exercise helps keep our bodies healthy and strong. […] If you have lesions from mastocytosis, or tend toward hives with your MCD, one thing you can do to minimize irritation and itching is to have good regular skin care.

• #88 Mastocytosis

  https://www.rch.org.au/kidsinfo/fact_sheets/mastocytosis/

  Mastocytosis in children is likely to go away by itself after several years. Seven out of 10 children with mastocytosis affecting their skin can expect a big improvement by the time they are 10 years old. […] Often no medication is needed for mastocytosis. However, antihistamines may be used to relieve symptoms such as itching, and topical cortisone creams have been found to be helpful. You can buy these from your local chemist. You could also try applying cold, wet compresses to relieve the itch. […] It is important to be aware of the things that trigger or cause a response in your child, and avoid them if possible. Triggers may include: excess heat, drinking hot liquids, swimming in cold water, being emotional or stressed, some medications and food. […] Exercise can also trigger a response for some children, and while exercise should not be avoided, you should be aware that it may cause symptoms in your child.

• #89 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  Not all mast cell disease patients have foods that trigger them, but many do. […] Mast cells can be triggered by extreme temperatures and by changes in temperature. […] Patients are often triggered by the smell of cleaning chemicals and perfumes. […] Some mast cell patients can tolerate drinking alcohol, but many cannot. […] Mast Cell Disease can be frustrating because it is unpredictable. […] We all know that exercise helps keep our bodies healthy and strong. […] If you have lesions from mastocytosis, or tend toward hives with your MCD, one thing you can do to minimize irritation and itching is to have good regular skin care.

• #90 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  With luck, you have found some medications that help you manage your mast cell disease, but there may be more you can do on your own to feel better. […] Many patients feel less anxious about their disease when they have EpiPens (or other epinephrine auto injector, such as Jext or Emerade) and other rescue medications with them. […] Mast cell disease experts generally recommend that patients carry TWO EPI-PENS at all times. […] If you are on a beta-blocker (a medication used for heart issues) you should ask your doctor about whether you ought to carry a glucagon pen to be used before you use an epi-pen. […] A medical alert bracelet speaks for you in a medical emergency when you cant speak. […] Consider using a pill organiser with boxes for each day of the week. […] Unless instructed by your doctor, DO NOT STOP TAKING YOUR MEDICATIONS just because youre feeling better.

• #91 Mastocytosis: Symptoms, Causes, and Treatment

  https://resources.healthgrades.com/right-care/allergies/mastocytosis

  People with mastocytosis should also have an epinephrine autoinjector for anaphylactic reactions. […] Living with mastocytosis requires being vigilant about potential allergens. When surgeries or other procedures are necessary, doctors must be sure to pre-medicate. […] Also, everyone with mastocytosis should have an epinephrine autoinjector. It can be life saving when it is not possible to avoid allergens. It is also important to wear medical identification jewelry so that others know how to help in an emergency.

• #92 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Referral to specialized centers with expertise in the management of mastocytosis is strongly recommended. […] Patients should be counseled about the signs and symptoms of mast cell activation and the importance of avoiding known triggers of mast cell activation. Anaphylactic reactions are significantly more frequent in patients with ISM and should be managed with the use of epinephrine injection. All patients should carry 2 auto injectors of epinephrine to manage anaphylaxis. […] Anti-mediator drug therapy for mast cell activation symptoms (as described in next section) is recommended for all patients with SM. […] Cytoreductive therapy (discussed in next section) is recommended for patients with advanced SM (ASM, SM-AHN, and MCL) because of the frequent presence of organ damage and shortened survival of this patient population. […] Enrollment in well-designed clinical trials investigating novel therapeutic strategies (eg, selective KIT D816 inhibitors) is encouraged to enable further advances.

• #93 Mastocytosis: Symptoms, Causes, and Treatment

  https://resources.healthgrades.com/right-care/allergies/mastocytosis

  People with mastocytosis should also have an epinephrine autoinjector for anaphylactic reactions. […] Living with mastocytosis requires being vigilant about potential allergens. When surgeries or other procedures are necessary, doctors must be sure to pre-medicate. […] Also, everyone with mastocytosis should have an epinephrine autoinjector. It can be life saving when it is not possible to avoid allergens. It is also important to wear medical identification jewelry so that others know how to help in an emergency.

• #94 Self-Care for Mast Cell Diseases – The UK Mastocytosis Support Group

  https://ukmasto.org/living-with-mcd/self-care-for-mast-cell-diseases/

  If your doctor has advised you to try a new medication to treat your mast cell disease, ask if you should start slowly. […] Patients diagnosed with any form of Systemic Mastocytosis qualify for free medications from NHS England because of its status as a neoplastic disease. […] Keep in mind that once youve read a few articles about mast cell disease, you have probably read more about it than your GP has. […] If you carry Epipens, bring them to your appointment and be sure youve taken your regular medications for your mast cell disease. […] If you are a regular visitor to the AE, talk with your consultant about preparing a protocol for what should be done there for you. […] Emotional stress can trigger mast cells to degranulate (release the chemicals stored inside them) and can be a direct trigger of a mast cell reaction.

• #95 Mastocytosis: What is It and How Is It Treated? | Dana-Farber Cancer Institute

  https://blog.dana-farber.org/insight/2017/12/mastocytosis-treatment/

  Mastocytosis is a rare type of mast cell disorder characterized by the abnormal accumulation of mast cells in various organ systems such as the skin, liver, spleen, intestine, or bone marrow. […] Systemic mastocytosis is diagnosed through a bone marrow aspiration and biopsy and may involve care by a hematologist/oncologist. […] These aggressive forms of systemic mastocytosis or mast cell leukemia are generally treated with chemotherapy. […] In June 2021, the U.S. Food and Drug Administration approved a precision drug, avapritinib (Ayvakit), to treat aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia. […] Since avapritinib is able to selectively target the primary driver of the disease, it has the potential to fundamentally change the outlook for patients with advanced systemic mastocytosis. […] Learn more about treatment for blood disorders from the Hematologic Oncology Treatment Center at Dana-Farber/Brigham and Womens Cancer Center.

• #96 Quest to find better treatments for rare blood cancer leads to new therapies | News Center

  https://med.stanford.edu/news/all-news/2022/03/systemic-mastocytosis-therapies.html

  Hematologist Jason Gotlib wanted more effective treatments for patients with systemic mastocytosis. His research has led to the approval of two new treatments by the Food and Drug Administration. […] „At that time, there was no FDA-approved treatment for patients with Sally’s form of the disease,” Worthen’s husband, Bill, a medical products specialist, recalled, using an abbreviation for the Food and Drug Administration. The only treatment was chemotherapy, which they were reluctant to pursue while Sally Worthen was feeling well. Instead, the couple devoted themselves to researching other options. […] Patients with SM can experience flushing, itching, diarrhea and, in some cases, life-threatening anaphylaxis. In advanced forms of the disease, the infiltration of organs by mast cells leads to signs of organ damage, such as low blood counts, liver-function abnormalities, malabsorption with weight loss, and bone fractures.

• #97 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  Before surgery, talk with your health care team about the possible side effects from the specific surgery you will have. […] Targeted therapy is a treatment that targets the disease’s specific genes, proteins or the tissue environment unique to mastocytosis that contribute to its growth and survival. […] A stem cell transplant is a medical procedure in which unhealthy bone marrow is replaced by highly specialised cells, called hematopoietic stem cells, that develop into healthy bone marrow. […] Chemotherapy is sometimes recommended if mastocytosis becomes cancerous. […] Mastocytosis treatment often causes side effects. In addition to treatment to manage the condition, an important part of treatment is relieving these side effects. […] Managing side effects is a critical component of treating individuals with Mast Cell Disease (MCD) as it has the ability to support overall quality of life. […] Regular and ongoing open communication between individuals with MCDs and their health care team is critical, as this supports mutual understandings which can provide for a holistic approach, where adjustments to treatment plans address all aspects of an individual’s needs.

• #98 Quest to find better treatments for rare blood cancer leads to new therapies | News Center

  https://med.stanford.edu/news/all-news/2022/03/systemic-mastocytosis-therapies.html

  „Overall, her quality of life was quite poor,” Gotlib said. […] Although a medication called imatinib, which is sold under the brand name Gleevec, has been approved for use in advanced SM, it is ineffective against the D816V mutation (although it may be useful in the rare SM patients who have normal KIT or other mutations in the gene). […] „Avapritinib is considerably more selective than midostaurin,” Gotlib said. „It was specifically designed to inhibit the KIT D816V mutation with very few other targets. Midostaurin was a big step forward in the treatment of advanced SM, but it hits several other targets, and avapritinib is more potent.” […] Of the 53 patients with advanced SM evaluated in the EXPLORER trial, 75% experienced at least some benefit from the drug and 36% of patients experienced a complete remission. The drug is not without side effects, which may include facial swelling, diarrhea, nausea and fatigue. There is also a risk of intracranial bleeding in people with low platelet counts.

• #99 Quest to find better treatments for rare blood cancer leads to new therapies | News Center

  https://med.stanford.edu/news/all-news/2022/03/systemic-mastocytosis-therapies.html

  „Overall, her quality of life was quite poor,” Gotlib said. […] Although a medication called imatinib, which is sold under the brand name Gleevec, has been approved for use in advanced SM, it is ineffective against the D816V mutation (although it may be useful in the rare SM patients who have normal KIT or other mutations in the gene). […] „Avapritinib is considerably more selective than midostaurin,” Gotlib said. „It was specifically designed to inhibit the KIT D816V mutation with very few other targets. Midostaurin was a big step forward in the treatment of advanced SM, but it hits several other targets, and avapritinib is more potent.” […] Of the 53 patients with advanced SM evaluated in the EXPLORER trial, 75% experienced at least some benefit from the drug and 36% of patients experienced a complete remission. The drug is not without side effects, which may include facial swelling, diarrhea, nausea and fatigue. There is also a risk of intracranial bleeding in people with low platelet counts.

• #100 Mastocytosis: What is It and How Is It Treated? | Dana-Farber Cancer Institute

  https://blog.dana-farber.org/insight/2017/12/mastocytosis-treatment/

  Mastocytosis is a rare type of mast cell disorder characterized by the abnormal accumulation of mast cells in various organ systems such as the skin, liver, spleen, intestine, or bone marrow. […] Systemic mastocytosis is diagnosed through a bone marrow aspiration and biopsy and may involve care by a hematologist/oncologist. […] These aggressive forms of systemic mastocytosis or mast cell leukemia are generally treated with chemotherapy. […] In June 2021, the U.S. Food and Drug Administration approved a precision drug, avapritinib (Ayvakit), to treat aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia. […] Since avapritinib is able to selectively target the primary driver of the disease, it has the potential to fundamentally change the outlook for patients with advanced systemic mastocytosis. […] Learn more about treatment for blood disorders from the Hematologic Oncology Treatment Center at Dana-Farber/Brigham and Womens Cancer Center.

• #101 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  Before surgery, talk with your health care team about the possible side effects from the specific surgery you will have. […] Targeted therapy is a treatment that targets the disease’s specific genes, proteins or the tissue environment unique to mastocytosis that contribute to its growth and survival. […] A stem cell transplant is a medical procedure in which unhealthy bone marrow is replaced by highly specialised cells, called hematopoietic stem cells, that develop into healthy bone marrow. […] Chemotherapy is sometimes recommended if mastocytosis becomes cancerous. […] Mastocytosis treatment often causes side effects. In addition to treatment to manage the condition, an important part of treatment is relieving these side effects. […] Managing side effects is a critical component of treating individuals with Mast Cell Disease (MCD) as it has the ability to support overall quality of life. […] Regular and ongoing open communication between individuals with MCDs and their health care team is critical, as this supports mutual understandings which can provide for a holistic approach, where adjustments to treatment plans address all aspects of an individual’s needs.

• #102 What are treatments for Systemic Mastocytosis? – HealthTree for Systemic Mastocytosis

  https://healthtree.org/mastocytosis/community/what-are-treatments-for-systemic-mastocytosis

  For patients with life-threatening systemic mastocytosis, allogeneic stem cell transplantation may be considered. This involves replacing the patient’s diseased bone marrow (which produces mast cells) with healthy bone marrow from a donor. This can potentially cure the disease, but it carries significant risks, including infection, graft-versus-host disease, and even death. Therefore, it is usually reserved for the most severe cases.

• #103 Mastocytosis Center – Brigham and Women’s Hospital

  https://www.brighamandwomens.org/medicine/allergy-clinical-immunology/allergy-mastocytosis-center?TRILIBIS_EMULATOR_UA=…%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%2Cgm%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn

  The Mastocytosis Center provides care for adults and children with mast cell activation disorders. This includes cutaneous mastocytosis, systemic mastocytosis, mast cell activation syndromes, idiopathic anaphylaxis, and hereditary alpha tryptasemia. […] We are able to care for complex patients through our extensive care team consisting of more than ten physicians in eight different medical specialties. […] We have developed treatment innovations such as the first ultra-rush venom desensitization protocol for patients with mastocytosis and life-threatening anaphylaxis to hymenoptera venom. […] Patients seen at the Mastocytosis Center are eligible to participate in ongoing clinical and/or translational research.

• #104 Roswell Park offers new hope for mast cell disorders | Roswell Park Comprehensive Cancer Center – Buffalo, NY

  https://www.roswellpark.org/cancertalk/202101/roswell-park-offers-new-hope-mast-cell-disorders

  After diagnosis, our focus turns to treatment, says Dr. Griffiths. Therapies for milder cases include treatment with steroids, antihistamines, epinephrine auto-injector pens (such as EpiPens) and working with patients to help them identify their mast cell triggers. […] Aggressive mastocytosis and mast cell leukemia usually require chemotherapy with midostaurin, currently the only FDA-approved drug for treatment of these diseases. […] We just completed phase 1 of a clinical trial for a new drug to treat these diseases, with very promising results, and will be conducting another clinical trial shortly.

• #105 Duke Blood Cancer Center Named Mast Cell Diseases Center of Excellence | Duke Health

  https://www.dukehealth.org/blog/duke-blood-cancer-center-named-mast-cell-diseases-center-of-excellence

  The Duke Blood Cancer Center has been recognized as a Center of Excellence by the American Initiative in Mast Cell Diseases Network. This designation acknowledges the centers expertise in caring for people with systemic mastocytosis and related mast cell disorders. […] The Duke Blood Cancer Center is one of a handful of centers in the Southeast with the experience and capability to treat mast cell diseases. […] Having experts in multiple specialties — including hematology, allergy and immunology, dermatology, and oncology — is essential for helping people manage these symptoms, treating their disease, and improving their quality of life. […] In addition to patient care, Dr. Rein and her colleagues are actively involved in research on new treatments for systemic mastocytosis and other mast cell diseases. […] While there is currently no cure for systemic mastocytosis and related mast cell disorders, receiving comprehensive care at a Mast Cell Diseases Center of Excellence can help people with these conditions live a full and fulfilling life.

• #106 Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)

  https://jnccn.org/view/journals/jnccn/16/12/article-p1500.xml

  Mastocytosis is a group of heterogeneous disorders resulting from the clonal proliferation of abnormal mast cells and their accumulation in the skin and/or in various extracutaneous organs. Systemic mastocytosis is the most common form of mastocytosis diagnosed in adults, characterized by mast cell infiltration of one or more extracutaneous organs (with or without skin involvement). […] The management of patients with mastocytosis requires a multidisciplinary team approach (involving dermatologists, hematologists, gastroenterologists, pathologists, and allergists/immunologists) preferably in specialized medical centers with expertise in the treatment of patients with mast cell disorders. […] These NCCN Guidelines provide recommendations for the diagnosis and management of patients with SM. Management of CM is not included in these guidelines. Referral to centers with expertise in CM is strongly recommended.

• #107 Systemic mastocytosis – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/care-at-mayo-clinic/mac-20352862

  Mayo Clinic doctors from several medical specialties work together to provide you with the best care possible. Your team may include specialists in allergic diseases, hematology, dermatology, gastroenterology, pediatrics, neurology, endocrinology and pathology. […] Your health care team will help you identify particular factors that may trigger your symptoms of systemic mastocytosis and work with you to help keep your symptoms under control. […] At Mayo Clinic, doctors manage systemic mastocytosis by regularly monitoring your condition, then tailoring a treatment plan to help you manage your specific symptoms. […] Mayo Clinic is one of the only centers to offer a special home kit that you can use to collect blood and urine samples while you’re experiencing symptoms, which gives your doctor a better picture of how systemic mastocytosis affects your body. […] Mayo Clinic doctors have experience diagnosing and caring for people with all types of systemic mastocytosis.

• #108 Treatment – The Australasian Mastocytosis Society

  https://mastocytosis.org.au/mast-cells-explained/treatment/

  There is no cure for mastocytosis, several treatments can be used to relieve symptoms. Take time to learn about all of your treatment options and be sure to ask questions about things that are unclear. Talk with your health care team about the goals of each treatment from a medical and individual (personal) perspective, ensuring quality of life goals are always supported. […] An important part of treating mastocytosis is controlling a person’s symptoms. One important way to do this is to avoid anything that may cause mast cells to release mediators like histamine, one of hundreds of mediators. This may include extreme temperatures, alcohol, emotional stress, insect bites and certain medications. […] Doctors may recommend the following treatments to help manage symptoms of mastocytosis.

• #109 Critical care management of systemic mastocytosis: when every wasp is a killer bee | Critical Care | Full Text

  https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0956-z

  When a patient with known mastocytosis is admitted to the ICU, it may be helpful to make a risk profile to estimate the chance of developing anaphylactoid reactions. […] Histamine-releasing drugs, such as opioids and neuromuscular blocking agents, should be avoided. […] When (surgical) intervention is planned during ICU admission, precautions must be taken. […] Pre-medication may include benzodiazepines, H1- and H2-receptor antagonists to block the cascade of mast cell mediators, and glucocorticoids as anti-inflammatory and mast cell stabilizers. […] Knowledge of the pathophysiology of the disease is of paramount importance for adequate treatment and the prevention of secondary events of mast cell degranulation due to mechanical or pharmacological triggers. […] During treatment, physicians should avoid potential triggers of mast cell degranulation, consider giving pre-medication before interventions, and be aware of and prepared for the clinical manifestations caused by mast cell mediators. […] Avoiding medication and physical stimuli that trigger histamine release and blocking the cascade of actions of mast cells constitute the mainstay of therapy besides treatment of anaphylaxis.

• #110 Duke Blood Cancer Center Named Mast Cell Diseases Center of Excellence | Duke Health

  https://www.dukehealth.org/blog/duke-blood-cancer-center-named-mast-cell-diseases-center-of-excellence

  The Duke Blood Cancer Center has been recognized as a Center of Excellence by the American Initiative in Mast Cell Diseases Network. This designation acknowledges the centers expertise in caring for people with systemic mastocytosis and related mast cell disorders. […] The Duke Blood Cancer Center is one of a handful of centers in the Southeast with the experience and capability to treat mast cell diseases. […] Having experts in multiple specialties — including hematology, allergy and immunology, dermatology, and oncology — is essential for helping people manage these symptoms, treating their disease, and improving their quality of life. […] In addition to patient care, Dr. Rein and her colleagues are actively involved in research on new treatments for systemic mastocytosis and other mast cell diseases. […] While there is currently no cure for systemic mastocytosis and related mast cell disorders, receiving comprehensive care at a Mast Cell Diseases Center of Excellence can help people with these conditions live a full and fulfilling life.

• #111 Quest to find better treatments for rare blood cancer leads to new therapies | News Center

  https://med.stanford.edu/news/all-news/2022/03/systemic-mastocytosis-therapies.html

  „We now have two drugs approved for the front-line treatment of advanced SM,” Gotlib said. „This is a really beautiful example of the effectiveness of targeted therapy for a rare disease, and I’m delighted to see how it has improved the lives of these patients.” […] The treatment allowed Worthen to get her life back, including a return to horseback riding. She now relies on regular blood tests to ensure her disease has not returned. „Slowly I got stronger, and I’m now feeling back to where I was before I became ill,” she said. „I feel very, very lucky and thankful.”

Zobacz więcej